The Global Alliance for Vaccines and Immunization (GAVI) has officially announced its approval of Ghana’s application for Hepatitis B birth dose vaccines.
The vaccines expected to arrive in the country in September this year, will resolve the issue of mother to child and early childhood transmission of the virus in the country.
Over the past two decades, Global Alliance for Vaccines and Immunization has been the backbone of Ghana’s immunization drive.
Making significant strides in the elimination of some childhood killer diseases, introduction of new vaccines, building resilient systems, and reaching children in areas where healthcare is once inaccessible.
Ghana is currently preparing to transition from GAVI support by 2030.
But the approval of the two new vaccines, the Hepatitis B birth dose and the HPV vaccine, would be milestone in the country’s vaccination drive when rolled out this year
Dr. Sania Nishtar, GAVI CEO, during a media engagement affirmed the global vaccine alliances support towards Ghana’s announcement of the approval of the country’s application.
“The country has consistently maintained DBT one and DPT three coverage above ninety-five percent. You have introduced thirteen antigens into your routine programs. And I just heard you talk about the HPV multi age cohort launch that you look forward to the introduction of the Hepatitis B birth dose. Very pleased to let you know that our independent review committee has approved your application. And we really look forward to supporting you in the roll out of the two new vaccines in September this year,’’ she announced.
This will be a significant drive towards efforts by government to fight vaccine preventable disease while transitioning toward self-financing its immunization programs.
Health Minister, Kwabena Mintah Akandoh, emphasized the importance of the approval of the vaccines for the country recounting government efforts to ensure it is self-sufficient.
“We are particularly excited to introduce the two new vaccines later this year—the Hepatitis B birth dose and the HPV vaccine. These will help us tackle cervical cancer and chronic liver disease, and we are grateful to GAVI for your technical and financial support in making them possible.
We recognize that GAVI’s support won’t last forever, and we welcome that—it’s a sign of national growth.
The recent removal of the NHIL cap and the 13% increase in our 2025 health budget represent positive steps. We are also collaborating with the Ministry of Finance to secure earmarked budget lines for vaccines. However, we will need your continued support and advocacy to help ensure that these gains are sustainable,” Mr Akandoh said.
In Ghana, approximately 2.8 million people are living with Hepatitis B Virus while approximately 14, 000 deaths recorded yearly are due to HBV.
Half the burden of chronic Hepatitis B and C infections is among people 30-54 years old, with 12% among children under 18 years of age.
